We are on track for IDE Submission to use RadioGel® in human clinical trials.
We are on track for IDE Submission to use RadioGel® in human clinical trials.
Vivos Inc. holds the patent for Precision Radionuclide Therapy™ (PRnT™) which is changing the way cancer is treated in animals. Currently we have been treating cats, dogs and horses in 8 regional clinics across the USA since 2018.